These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3150786)

  • 21. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro.
    Athreya BH; Pletcher J; Zulian F; Weiner DB; Williams WV
    Clin Immunol Immunopathol; 1993 Mar; 66(3):201-11. PubMed ID: 8094329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal, and gonadal hormones during the early follicular phase of the menstrual cycle.
    Teoh SK; Mendelson JH; Mello NK; Skupny A
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1181-6. PubMed ID: 3372681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the gonadotrophic responsiveness of the pituitary to acute and prolonged administration of LH/FSH-releasing hormone (LH-RH) in normal females and males.
    Pinto H; Wajchenberg BL; Lima FB; Goldman J; Comaru-Schally AM; Schally AV
    Acta Endocrinol (Copenh); 1979 May; 91(1):1-13. PubMed ID: 377880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axis.
    Zähringer S; Tomova A; von Werder K; Brabant G; Kumanov P; Schopohl J
    Exp Clin Endocrinol Diabetes; 2000; 108(4):282-9. PubMed ID: 10961359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone ontogeny in the ovine fetus: XIV. The effect of 17 beta-estradiol infusion on fetal plasma gonadotropins and prolactin and the maturation of sex steroid-dependent negative feedback.
    Gluckman PD; Marti-Henneberg C; Kaplan SL; Grumbach MM
    Endocrinology; 1983 May; 112(5):1618-23. PubMed ID: 6403330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadal regulation of gonadotropin subunit gene expression: evidence for regulation of follicle-stimulating hormone-beta messenger ribonucleic acid by nonsteroidal hormones in female rats.
    Dalkin AC; Haisenleder DJ; Ortolano GA; Suhr A; Marshall JC
    Endocrinology; 1990 Aug; 127(2):798-806. PubMed ID: 2115433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periovulatory hormonal dynamics: relationship of immunoassayable gonadotropins and ovarian steroids to the bioassayable luteinizing hormone surge in rhesus monkeys.
    Schenken RS; Werlin LB; Williams RF; Prihoda TJ; Hodgen GD
    J Clin Endocrinol Metab; 1985 May; 60(5):886-90. PubMed ID: 3920234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone inhibits the estrogen-induced gonadotropin surge in the rhesus monkey independent of endogenous opiates.
    Van Vugt DA; Heisler LE; Reid RL
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1312-9. PubMed ID: 1592876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal evaluation of the luteal phase and its transition into the follicular phase.
    Vermesh M; Kletzky OA
    J Clin Endocrinol Metab; 1987 Oct; 65(4):653-8. PubMed ID: 3116029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine control of the seasonal occurrence of ovulation in rhesus monkeys housed outdoors.
    Walker ML; Wilson ME; Gordon TP
    Endocrinology; 1984 Apr; 114(4):1074-81. PubMed ID: 6423367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dexamethasone and dexamethasone plus naltrexone on pituitary response to GnRH and TRH in normal women.
    la Marca A; Torricelli M; Morgante G; Lanzetta D; De Leo V
    Horm Res; 1999; 51(2):85-90. PubMed ID: 10352398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
    Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R
    J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.